Johnson & Johnson Innovation - JJDC, Inc.'s Net Worth

$506 Million

Who is Johnson & Johnson Innovation - JJDC, Inc.?

Johnson & Johnson Innovation - JJDC, Inc. has an estimated net worth of $506 Million. This is based on reported shares across multiple companies, which include CVRx, Inc., Fusion Pharmaceuticals Inc., Provention Bio, Inc., Inspire Medical Systems, Inc., ACHILLION PHARMACEUTICALS INC, Minerva Neurosciences, Inc., Protagonist Therapeutics, Inc, AQUINOX PHARMACEUTICALS, INC, NEVRO CORP, Aldeyra Therapeutics, Inc., GENOCEA BIOSCIENCES, INC., TENGION INC, BARRIER THERAPEUTICS INC, IMMUNICON CORP, CRITICAL THERAPEUTICS INC, UNIVERSAL BIOSENSORS INC, and MeiraGTx Holdings plc.

SEC CIK

Johnson & Johnson Innovation - JJDC, Inc.'s CIK is 0000924020

Past Insider Trading and Trends

2014 was Johnson & Johnson Innovation - JJDC, Inc.'s most active year for acquiring shares with 9 total transactions. Johnson & Johnson Innovation - JJDC, Inc.'s most active month to acquire stocks was the month of May. 2014 was Johnson & Johnson Innovation - JJDC, Inc.'s most active year for disposing of shares, totalling 38 transactions. Johnson & Johnson Innovation - JJDC, Inc.'s most active month to dispose stocks was the month of August. 2020 saw Johnson & Johnson Innovation - JJDC, Inc. paying a total of $12,325,000.00 for 3,759,634 shares, this is the most they've acquired in one year. In 2017 Johnson & Johnson Innovation - JJDC, Inc. cashed out on 22,259,602 shares for a total of $50,510,590.73, their largest year based on trade value.